BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 38401248)

  • 1. Moving toward precision medicine to predict drug sensitivity in patients with metastatic breast cancer.
    Bottosso M; Mosele F; Michiels S; Cournède PH; Dogan S; Labaki C; André F
    ESMO Open; 2024 Mar; 9(3):102247. PubMed ID: 38401248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advancements and Innovations in Pediatric Precision Oncology.
    Mangum R; Lin FY; Parsons DW
    J Pediatr Hematol Oncol; 2024 Jul; 46(5):262-271. PubMed ID: 38857189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating functional genomics into the pathology-supported genetic testing framework implemented in South Africa: A future view of precision medicine for breast carcinomas.
    Christowitz C; Olivier DW; Schneider JW; Kotze MJ; Engelbrecht AM
    Mutat Res Rev Mutat Res; 2024; 793():108492. PubMed ID: 38631437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer.
    Jiang M; Yang J; Li K; Liu J; Jing X; Tang M
    Int J Med Sci; 2021; 18(3):626-638. PubMed ID: 33437197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Themis: advancing precision oncology through comprehensive molecular subtyping and optimization.
    Xi Y; Zheng K; Deng F; Liu Y; Sun H; Zheng Y; Tong HHY; Ji Y; Zhang Y; Chen W; Zhang Y; Zou X; Hao J
    Brief Bioinform; 2024 May; 25(4):. PubMed ID: 38833322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomics in Clinical trials for Breast Cancer.
    Enoma D
    Brief Funct Genomics; 2023 Dec; ():. PubMed ID: 38146120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current State of Personalized Genitourinary Cancer Radiotherapy in the Era of Precision Medicine.
    Kamran SC; Efstathiou JA
    Front Oncol; 2021; 11():675311. PubMed ID: 34026653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic breast cancer: The Odyssey of personalization.
    Sonnenblick A; Pondé N; Piccart M
    Mol Oncol; 2016 Oct; 10(8):1147-59. PubMed ID: 27430154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision oncology for breast cancer through clinical trials.
    Blucher AS; Mills GB; Tsang YH
    Clin Exp Metastasis; 2022 Feb; 39(1):71-78. PubMed ID: 33950412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and Treatment of Breast Cancer in the Precision Medicine Era.
    Yan J; Liu Z; Du S; Li J; Ma L; Li L
    Methods Mol Biol; 2020; 2204():53-61. PubMed ID: 32710314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference.
    Hall WA; Bergom C; Thompson RF; Baschnagel AM; Vijayakumar S; Willers H; Li XA; Schultz CJ; Wilson GD; West CML; Capala J; Coleman CN; Torres-Roca JF; Weidhaas J; Feng FY
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):274-284. PubMed ID: 28964588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspiring toward equitable benefits from genomic advances to individuals of ancestrally diverse backgrounds.
    Wang Y; He Y; Shi Y; Qian DC; Gray KJ; Winn R; Martin AR
    Am J Hum Genet; 2024 May; 111(5):809-824. PubMed ID: 38642557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.
    Cheng F; Hong H; Yang S; Wei Y
    Brief Bioinform; 2017 Jul; 18(4):682-697. PubMed ID: 27296652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are innovation and new technologies in precision medicine paving a new era in patients centric care?
    Seyhan AA; Carini C
    J Transl Med; 2019 Apr; 17(1):114. PubMed ID: 30953518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current advances in the diagnosis and personalized treatment of breast cancer: lessons from tumor biology.
    Kern R; Correa SC; Scandolara TB; Carla da Silva J; Pires BR; Panis C
    Per Med; 2020 Sep; 17(5):399-420. PubMed ID: 32804054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of cancer genomic heterogeneity by next-generation sequencing advances precision medicine in cancer treatment.
    Zhang J; Späth SS; Marjani SL; Zhang W; Pan X
    Precis Clin Med; 2018 Jun; 1(1):29-48. PubMed ID: 30687561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing precision cancer medicine in the genomic era.
    Chen HZ; Bonneville R; Roychowdhury S
    Semin Cancer Biol; 2019 Apr; 55():16-27. PubMed ID: 29857039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic Breast Cancer With ESR1 Mutation: Clinical Management Considerations From the Molecular and Precision Medicine (MAP) Tumor Board at Massachusetts General Hospital.
    Bardia A; Iafrate JA; Sundaresan T; Younger J; Nardi V
    Oncologist; 2016 Sep; 21(9):1035-40. PubMed ID: 27551012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translating genomics in cancer care.
    Bombard Y; Bach PB; Offit K
    J Natl Compr Canc Netw; 2013 Nov; 11(11):1343-53. PubMed ID: 24225968
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.